YOLO vs. FTXH ETF Comparison

Comparison of AdvisorShares Pure Cannabis ETF (YOLO) to First Trust Nasdaq Pharmaceuticals ETF (FTXH)
YOLO

AdvisorShares Pure Cannabis ETF

YOLO Description

Cannabis and its various applications have been used throughout human civilization for over 5,000 years. As society, business and regulatory landscapes evolve in the 21st century, the upside potential of cannabis as an emerging investment avenue has arrived. The portfolio manager believes today’s new era can be viewed in similar regard to post-Prohibition, commencing a growing acknowledgement and understanding of cannabis and its uses among a mainstream audience. The industries that comprise the multi-billion dollar cannabis universe represent a new frontier, where proper caution and due diligence must be exercised surrounding its regulations and risks, in seeking attractive long-term cannabis investment opportunities. The AdvisorShares Pure Cannabis ETF (Ticker: YOLO) became the first actively managed ETF with a dedicated cannabis investment mandate domiciled in the United States. The AdvisorShares Pure Cannabis ETF, or YOLO, seeks long-term capital appreciation by investing in both domestic and foreign cannabis equity securities. YOLO is designed to fully-invest for pure cannabis exposure under the guidance of a deeply experienced portfolio management team navigating the emerging cannabis marketplace.

Grade (RS Rating)

Last Trade

$2.71

Average Daily Volume

52,696

Number of Holdings *

9

* may have additional holdings in another (foreign) market
FTXH

First Trust Nasdaq Pharmaceuticals ETF

FTXH Description The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.

Grade (RS Rating)

Last Trade

$27.10

Average Daily Volume

3,490

Number of Holdings *

50

* may have additional holdings in another (foreign) market
Performance
Period YOLO FTXH
30 Days -16.62% -6.26%
60 Days -17.60% -7.87%
90 Days -21.60% -4.97%
12 Months -0.46% 12.93%
1 Overlapping Holdings
Symbol Grade Weight in YOLO Weight in FTXH Overlap
JAZZ A 3.63% 3.2% 3.2%
YOLO Overweight 8 Positions Relative to FTXH
Symbol Grade Weight
MSOS F 35.08%
HITI B 11.58%
SNDL F 7.02%
REFI A 4.06%
OGI F 3.38%
AFCG F 3.33%
TLRY F 2.28%
INM B 0.62%
YOLO Underweight 49 Positions Relative to FTXH
Symbol Grade Weight
BMY B -8.03%
ABBV F -7.49%
PFE F -6.94%
JNJ D -6.93%
MRK F -6.26%
GILD B -4.54%
VTRS A -4.0%
UTHR B -3.92%
CAH B -3.85%
AMGN D -3.54%
ZTS D -3.48%
BIIB F -3.12%
LLY F -3.04%
CRL D -2.55%
REGN F -2.55%
OGN F -2.47%
ELAN C -1.83%
MEDP D -1.83%
NBIX D -1.35%
HALO D -1.27%
EXEL B -1.11%
ALKS B -1.05%
PRGO C -0.94%
PBH A -0.91%
PTGX D -0.79%
CORT B -0.78%
ACLX C -0.73%
ALNY D -0.66%
INCY B -0.64%
ITCI B -0.63%
TGTX B -0.6%
ADMA C -0.58%
VKTX F -0.55%
RNA C -0.55%
TWST F -0.54%
BPMC D -0.54%
KYMR C -0.53%
ACAD C -0.53%
AMRX C -0.51%
VRTX C -0.51%
ROIV D -0.49%
VCEL A -0.49%
INSM D -0.48%
KRYS D -0.48%
SRPT F -0.45%
EXAS F -0.44%
BMRN F -0.42%
IONS F -0.41%
MYGN F -0.32%
Compare ETFs